Onishi et al. [74], detected the genetic polymorphism of TNF-α (α1, α2) and TNF-β (β1, β2). All patients having TNF-β1/1 homozygote were alive, and a significantly favourable prognosis in the patients with TNF-β1/1 homozygote compared with other TNF-β polymorphism was observed. In the Turkish population, rs1800629 polymorphism is associated with an increased risk of hepatocellular carcinoma

as this polymorphism plays role in the regulation of expression level. A case–control study Selleck RG-7388 was designed by Akkiz et al. [75], and they found that rs1800629 genotype was significantly associated with the risk of HCC. The presence of the high producer allele rs1800629 A in the TNF-α gene was associated with an increased risk of the development of HCC in Turkish population. Acute pancreatitis.  Tumour necrosis factor α (TNFα) plays important roles

in the pathogenesis of acute pancreatitis (AP). Ozhan et al. [76] determined two TNF promoter polymorphisms (rs1800629 and rs361525) in patients with AP and healthy controls. The frequencies of these polymorphisms were similar in both patients with mild or severe pancreatitis and in controls. Sarcoidosis is a complex disease with autoimmune basis, a multisystemic granulomatous disorder which occurs in almost all populations. Disease manifestations are localized to lung and skin, but the involvement of other parts such as eyes, lymph nodes, parotid glands, heart, liver and spleen can also occur. Sharma et al. [25] reported for the first

time the association of TNF haplotypes and genotypes with sarcoidosis and its prognosis in the Indian population. Selleckchem Pifithrin �� Five promoter polymorphism in the TNF-α gene Clomifene and one in LTα gene (rs909253) were genotyped in North Indian patients. They have measured sTNF-α and serum angiotensin–converting enzyme (SACE) levels. Serum TNF-alpha and SACE levels are influenced by rs1800629 and rs361525 polymorphisms. The patients and controls have significant differences in haplotype frequencies. The haplotype GTCCGG was identified as the major risk/susceptibility haplotype and was associated with increased SACE levels in the patients. Cystic fibrosis conductance regulator, tumour necrosis factor, interferon-alpha-10, interferon-alpha-17 and interferon-gamma genotyping as potential risk markers in pulmonary sarcoidosis pathogenesis were detected by Makrythanasis et al. [77], in Greek patients. They have detected a statistically significant increase of CFTR mutation carriers in patients with sarcoidosis than in the control population. A difference was observed within sarcoidosis patients group where patients with CFTR mutations suffered more frequently from dyspnoea than those without. Tumour necrosis factor (TNF-α), a proinflammatory cytokine, plays an important role in multiple sclerosis (MS) pathogenesis. In Turkish population, Akcali et al.